INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS

Inclusion to the clinical practice of genetically engineered biological medications opens new opportunities in treatment of juvenile arthritis. The article summarizes an experience of treatment of juvenile arthritis with infliximab in children’s department of Scientific Center of Rheumatology, Russi...

Full description

Bibliographic Details
Main Authors: I.P. Nikishina, S.R. Rodionovskaya, A.N. Shapovalenko, E.S. Fedorov, D.L. Alekseev
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-01-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:https://vsp.spr-journal.ru/jour/article/view/842